Atrin Pharmaceuticals
Doylestown, US
Biotech
Founders & leadership
BC
Bernard C. RudnickExecutive Officer, Director
OG
Oren GiladExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements$1.5MraisedApr 2016 · 9 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.